Showing results (951-960 of 1,237) with videos related to

Sort By:
Pageof 124
Cancer|January 10, 2001
Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcomeT Safra, S Groshen, S Jeffers, et al.
Msphere|February 8, 2017
TgPRELID, a Mitochondrial Protein Linked to Multidrug Resistance in the Parasite Toxoplasma gondiiVictoria Jeffers, Edwin T Kamau, Ananth R Srinivasan, et al.
British Medical Journal|July 17, 1976
Methyldopa and propranolol or practolol in moderate hypertensionJ C Petrie, D B Galloway, T A Jeffers, et al.
Hepatology (Baltimore, Md.)|July 1, 1991
Immunophenotyping of lymphocytes in liver tissue of patients with chronic liver diseases by flow cytometryX M Li, L J Jeffers, K R Reddy, et al.
Biomaterials|January 6, 2019
Individual response variations in scaffold-guided bone regeneration are determined by independent strain- and injury-induced mechanismsNatalie Reznikov, Oliver R Boughton, Shaaz Ghouse, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|May 6, 2021
High Return to Play and Low Reinjury Rates in National Collegiate Athletic Association Division I Football Players Following Anterior Cruciate Ligament Reconstruction Using Quadrupled Hamstring AutograftKirk W Jeffers, Sagar A Shah, Derek D Calvert, et al.
The American Journal of Gastroenterology|September 1, 1995
Procollagen-III peptide and chronic viral C hepatitisL J Jeffers, M E Coelho-Little, H Cheinquer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity studyV K Israel, C Jiang, F M Muggia, et al.
Plant Disease|January 30, 2019
QTL Mapping for Gray Leaf Spot Resistance in a Tropical Maize PopulationL Liu, Y D Zhang, H Y Li, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal womenMatt S Anderson, Isaias Noel Gendrano, Chengcheng Liu, et al.
Pageof 124